ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623902 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623902; 2) Community: the network communities that were significantly associated with the response to NSC 623902; 3) Molecule: the relationships between components within communities and NSC 623902; 4) MDR: the compounds that were significantly associated with the NSC 623902.

NSC Compound Enrichment Correlation
NSC 18805 .gamma.-Thujaplicine 0.0114553853234977 0.30897751
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0114553853234977 0.31848884
NSC 244404 Null 0.0114553853234977 0.19117527
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.0114553853234977 0.1925507
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0114553853234977 0.33373797
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0114553853234977 0.31330803
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0114553853234977 0.35293982
NSC 603071 Aminocamptothecin 0.0114553853234977 0.14031235
NSC 606497 Camptothecin Derivative 0.0114553853234977 0.20402388
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 0.0131142867047947 0.34042956
Total:89  Current:27    [First] [Prev] [Next] [Last]